Usher Syndromes Clinical Trials
2 recruiting trials for Usher Syndromes. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Usher Syndromes clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (1), Food and Drug Administration (FDA) (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Adaptive optics imaging (device, 1 trial).
Track Usher Syndromes trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Natural History Study of Usher Syndrome ( Light4Deaf )
Clinical centres in the LIGHT4DEAF consortium have developed and will continue to improve a reliable, early molecular diagnosis and protocols for full clinical characterisation of...
Adaptive Optics Imaging of Outer Retinal Diseases
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Usher Syndromes, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Usher Syndromes, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Usher Syndromes, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.